10% Owner Sells $33M in Diebold Nixdorf Stock Near 52-Week High
DBD has more than doubled off its 52-week low of $36.425.
Summary
Millstreet Capital Management and its managing members, a 10% owner of Diebold Nixdorf, sold over $32.9 million worth of common stock, reducing their stake while the stock trades near its 52-week high.
Key Events · Ownership and Investor Activity · DBD
-
Significant Insider Sale
Millstreet Capital Management LLC, a 10% owner, along with managing members Brian D Connolly and Craig Kelleher, disposed of 399,929 shares of common stock.
-
Substantial Value
The open market sale totaled $32,960,468 at an average price of $82.42 per share on April 8, 2026.
-
Position Reduction
This transaction reduces their collective holdings to 4,816,743 shares, representing a 7.66% reduction in their prior stake.
-
Timing Near 52-Week High
The sale occurred while Diebold Nixdorf's stock is trading near its 52-week high of $85.99, potentially indicating profit-taking.
Analysis · DBD · Technology
This significant open market sale by a 10% institutional owner, Millstreet Capital Management, and its managing members, represents a substantial disposition of shares. While not an operational insider, the sale of over $32.9 million worth of stock, equivalent to more than 1% of the company's market capitalization, indicates a notable reduction in their position. The transaction occurred with the stock trading near its 52-week high, suggesting the investors may be locking in gains. This follows Diebold Nixdorf's strong financial rebound reported in February, which included a new share repurchase program, but this sale by a major investor could introduce some selling pressure.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DBD was trading at $84.78 on NYSE in the Technology sector, with a market capitalization of approximately $3B. The 52-week trading range was $36.43 to $85.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.